• White House tells states to use or lose their COVID-19 vaccine supply: WaPo

    9 days ago - By Business Insider

    Summary List Placement With rates of COVID-19 vaccine doses tapering off in the United States, the White House is telling states they need to either use or lose their vaccine supply, The Washington Post reported on Tuesday.
    Four months into the US's vaccine rollout, the seven-day average of vaccine doses administered has fallen from a peak of 3.5 million doses per day in mid-April to 2.3 million in early May, according to The New York Times. As of Tuesday, 56% of the US's adult population - people who are 18 or older - have received at least one shot and 40% have been fully vaccinated.
    The...
    Read more ...

     

  • Vaccine sales power Pfizer through first quarter

    Vaccine sales power Pfizer through first quarter

    9 days ago - By Stl Today

    Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid performance across most of the company, is hiking its 2021 financial forecast sharply after blowing past Wall Street expectations for the first quarter.
    Read more ...

     

  • Pfizer brought in $3.5 billion from COVID-19 vaccine sales in the first 3 months of 2021

    Pfizer brought in $3.5 billion from COVID-19 vaccine sales in the first 3 months of 2021

    9 days ago - By Business Insider

    Summary List Placement Pfizer has sold hundreds of millions of doses of its COVID-19 vaccine to the United States, and even more around the globe, resulting in more than $3.5 billion in revenue during the first three months of 2021, the company said Tuesday.
    Sales of the two-shot vaccine made up nearly a quarter of the pharmaceutical giant's first-quarter revenues of $14.6 billion, easily its biggest income driver, though the company has been tight-lipped about how those sales translate to profits.
    Shares of Pfizer were little changed in early trading Tuesday following the results.
    Pfizer...
    Read more ...

     

  • One slide lays out Pfizer's busy 2021 plans for its COVID-19 vaccine, including when it could start being used in kids

    One slide lays out Pfizer's busy 2021 plans for its COVID-19 vaccine, including when it could start being used in kids

    9 days ago - By Business Insider

    Summary List Placement Pfizer outlined a busy 2021 for its coronavirus vaccine on Tuesday, as executives for the drugmaker projected the shot will bring in $26 billion in revenues on the year.
    Even though the shot is already authorized in the US and elsewhere, there's tons of research going on to expand the vaccine's impact. In particular, Pfizer is studying the vaccine in children of all ages, going all the way down to babies. The company also expects to have data this year for a new version of its shot that doesn't need to kept at any unusually low temperatures.
    Pfizer's shot...
    Read more ...

     

  • Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%

    Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%

    9 days ago - By Business Insider

    Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study.
    Dado Ruvic/Reuters
    Shares of Pfizer rose on Tuesday after the drugmaker raised its COVID-19 forecast for 2021.
    The company now expects vaccine revenues of around $26 billion, 73% higher than the $15 billion initial target.
    In the first quarter, Pfizer said its vaccine drew $3.5 billion in sales during the first quarter from more than 50 countries.
    Sign up here for our daily newsletter, 10 Things Before the Opening Bell .
    Shares of Pfizer rose on Tuesday after the drugmaker raised...
    Read more ...

     

  • As Americans think about booking a vacation, RT's Boom Bust asks if airlines are ready for a travel surge after a slow year

    As Americans think about booking a vacation, RT's Boom Bust asks if airlines are ready for a travel surge after a slow year

    9 days ago - By RT

    With Covid-19 cases falling, the vaccine rollout continuing apace, and restrictions gradually being lifted, millions of Americans are looking forward to traveling again.
    According to the US Travel Association, 72% of Americans are planning a summer trip this year, compared to 37% last year. However, despite the increase in demand, the airline industry is still expected to lose $48 billion in 2021. RT's Boom Bust talked to travel writer Gary Leff to find out if the travel industry is seeing any new shoots of recovery.
    “The airline industry is basically ready, because the frontline employees...
    Read more ...

     

  • Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%

    Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%

    9 days ago - By Business Insider

    Summary List Placement Shares of Pfizer rose on Tuesday after the drugmaker raised forecasts for 2021 on the expectation of stronger full-year earnings than previously expected.
    The New York-based drugmaker said it now expects COVID-19 vaccine revenues of around $26 billion, 73% higher than the $15 billion initial target , and now sees adjusted earnings per share of $3.55-$3.65, up from $3.10-$3.20, according to a statement Tuesday.
    The company also said it aims to manufacture up to 2.5 billion doses in 2021 - having contracted around 1.6 billion vaccine doses to be delivered this year as...
    Read more ...

     

  • Pfizer Will File For Full FDA Approval For Covid-19 Vaccine By End Of May

    9 days ago - By Forbes

    Full FDA approval would allow the vaccine to be administered after the Covid-19 pandemic ends.
    Read more ...